eciskafusp alfa (RG6279) / Roche 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
eciskafusp alfa (RG6279) / Roche
NCT04303858: A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

Active, not recruiting
1
189
Europe, Canada
Eciskafusp Alfa, RO7284755, Atezolizumab, Tecentriq
Hoffmann-La Roche
Solid Tumors
11/26
05/27

Download Options